Tumor necrosis factor-α induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-κB in A549 cells

Toxicology and Applied Pharmacology

Volumn 229, Issue 3, 2008, Pages 386-398

  Lin, Chih Chung ^a   Tseng, Hsiao Wei ^a   Hsieh, Hsi Lung ^a   Lee, Chiang Wen ^a   Wu, Cheng Ying ^a   Cheng, Ching Yi ^a   Yang, Chuen Mao ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Airway inflammation; Mitogen activated protein kinases; Signaling transduction; Transcription factor

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOHEXIMIDE; DACTINOMYCIN; GELATINASE B; HELENALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PROTEIN P42; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UO 126;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE; ZYMOGRAPHY;

BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUCIFERASES; MATRIX METALLOPROTEINASE 9; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NF-KAPPA B; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 44349188184     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2008.01.032     Document Type: Article

References (73)

1. Arai K., Lee S.R., and Lo E.H. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes. Glia 43 (2003) 254-264
2. Atkinson J.J., and Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 28 (2003) 12-24
3. Barnes P.J., and Karin M. Nuclear factor-kB - A pivotal transcription factor in chronic inflammation. N. Engl. J. Med. 336 (1997) 1066-1071
4. Becky K.E.A., Busse W.W., and Jarjour N.N. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am. J. Respir. Crit. Care Med. 162 (2000) 1157-1161
5. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., and Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13681-13686
6. Benbow U., and Brinckerhoff C.E. The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol. 15 (1997) 519-526
7. Bian Z.M., Elner S.G., Yoshida A., Kunkel S.L., Su J., and Elner V.M. Activation of p38, ERK1/2 and NIK pathways is required for IL-1β and TNF-α-induced chemokine expression in human retinal pigment epithelial cells. Exp. Eye Res. 73 (2001) 111-121
8. Broide D.H., Lotz M., Cuomo A.J., Coburn D.A., Federman E.C., and Wasserman S.I. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89 (1992) 958-967
9. Cavigelli M., Dolfi F., Claret F.X., and Karin M. Induction of c-Fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14 (1995) 5957-5964
10. Chandrasekar B., Mummidi S., Mahimainathan L., Patel D.N., Bailey S.R., Imam S.Z., Greene W.C., and Valente A.J. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J. Biol. Chem. 281 (2006) 15099-15109
11. Chen G., Hitomi M., Han J., and Stacey D.W. The p38 pathway provides negative feedback for Ras proliferative signaling. J. Biol. Chem. 275 (2000) 38973-38980
12. Choo M.K., Sakurai H., Koizumi K., and Saiki I. Stimulation of cultured colon 26 cells with TNF-α promotes lung metastasis through the extracellular signal-regulated kinase pathway. Cancer Lett. 230 (2005) 47-56
13. Chung K.F. Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation?. Eur. Respir. J. 15 (2000) 961-968
14. Crapo J.D., Young S.L., Fram E.K., Pinkerton K.E., Barry B.E., and Crapo R.O. Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am. Rev. Respir. Dis. 128 (1983) S42-S46
15. Daniels S.E., Bhattacharrya S., James A., Leaves N.I., Young A., Hill M.R., Faux J.A., Ryan G.F., le Souef P.N., Lathrop G.M., Musk A.W., and Cookson W.O. A genome-wide search for quantitative trait loci underlying asthma. Nature 383 (1996) 247-250
16. Eberhardt W., Huwiler A., Beck K.F., Walpen S., and Pfeilschifter J. Amplification of IL-1β-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangila cells is mediated by increased activities of NF-kB and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165 (2000) 5788-5797
17. Eder J. Tumor necrosis factor alpha and interleukin 1 signalling: do MAPKK kinases connect it all?. Trends Pharmacol. Sci. 18 (1997) 319-322
18. Elshaw S.R., Henderson N., Knox A.J., Watson S.A., Buttle D.J., and Johnson S.R. Matrix metalloproteinase expression and activity in human airway smooth muscle cells. Br. J. Pharmacol. 142 (2004) 1318-1324
19. Esteve P.O., Chicoine E., Robledo O., Aoudjit F., Descoteauxt A., Potworowski E., and St-Pierre Y. Protein kinase C-ζ regulates transcription of the matrix metalloproteinase-9 gene induced by IL-1 and TNF-α in glioma cells via NF-kB. J. Biol. Chem. 277 (2002) 35150-35155
20. Fabunmi R.P., Baker A.H., Murray E.J., Booth R.F.G., and Newby A.C. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells. Biochem. J. 315 (1996) 335-342
21. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
22. Ghosh S., May M.J., and Kopp E.B. NF-kB and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
23. Gum R., Wang H., Lengyel E., Juarez J., and Boyd D. Regulation of 92 kDa type IV collagenases expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14 (1997) 1481-1493
24. Hah N., and Lee S.T. An absolute role of the PKC-dependent NF-kB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 305 (2003) 428-433
25. Han J., Lee J.D., Bibbs L., and Ulevitch R.J. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265 (1994) 808-811
26. Han Z., Boyle D.L., Chang L., Bennett B., Karin M., Yang L., Manning A.M., and Firestein G.S. C-Jun N-terminal kinase is required for metalloproteinase expression and joint destrccution in inflammatory arthritis. J. Clin. Invest. 108 (2001) 73-81
27. Hartlung H.P., and Kieseier B.C. The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system. J. Neuroimmunol. 107 (2000) 140-147
28. Heidinger M., Kolb H., Krell H.W., Jochum M., and Ries C. Modulation of autocrine TNF-α-stimulated matrix metalloproteinase 9 (MMP-9) expression by mitogen-activated protein kinases in THP-1 monocytic cells. Biol. Chem. 387 (2006) 69-78
29. Holvoet S., Vincent C., Schmitt D., and Serres M. The inhibition of MAPK pathway is correlated with down-regulation of MMP-9 secretion induced by TNF-α in human keratinocytes. Exp. Cell Res. 290 (2003) 108-119
30. Hozumi A., Nishimura Y., Nishiuma T., Kotani Y., and Yokoyama M. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-α via NF-kB-mediated pathway. Am. J. Physiol., Lung Cell. Mol. Physiol. 281 (2001) 1444-1452
31. Johnson S., and Knox A. Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. Am. J. Physiol., Lung Cell. Mol. Physiol. 277 (1999) L1109-L1117
32. Jung S.H., Woo M.S., Kim S.Y., Kim W.K., Hyun J.W., Kim E.J., Kim D.H., and Kim H.S. Ginseng saponin metabolite suppresses phorbol ester-induced matrix metalloproteinase-9 expression through inhibition of activator protein-1 and mitogen-activated protein kinase signaling pathways in human astroglioma cells. Int. J. Cancer 118 (2006) 490-497
33. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270 (1995) 16483-16486
34. Kim K.C., and Lee C.H. MAP kinase activation is required for the MMP-9 induction by TNF-stimulation. Arch. Pharm. Res. 28 (2005) 1257-1262
35. Kode A., Yang S.R., and Rahman I. Differential effects of cigarette smoke on oxidative stress and proinflammatory cytokine release in primary human airway epithelial cells and in a variety of transformed alveolar epithelial cells. Respir. Res. 7 (2006) 132
36. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., and Woodgett J.R. The stress-activated protein kinase subfamily of c-jun kinases. Nature 369 (1994) 156-160
37. Laitinen L.A., and Laitinen A. Inhaled corticosteroid treatment and extracellular matrix in the airways in asthma. Int. Arch. Allergy Immunol. 107 (1995) 215-216
38. Lee C.W., Chien C.S., and Yang C.M. Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 286 (2004) L921-L930
39. Lee W.J., Shin C.Y., Yoo B.K., Ryu J.R., Choi E.Y., Cheong J.H., Ryu J.H., and Ko K.H. Induction of matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide-stimulated primary astrocytes is mediated by extracellular signal-regulated protein kinase 1/2 (Erk1/2). Glia 41 (2003) 15-24
40. Liang K.C., Lee C.W., Lin W.N., Lin C.C., Wu C.B., Luo S.F., and Yang C.M. Interleukin-1β induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kB signaling pathways in human tracheal smooth muscle cells. J. Cell. Physiol. 211 (2007) 759-770
41. Lianxu C., Hongti J., and Changlong Y. NF-kB p65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1β-induced and TNF-α-induced chondrocytes. Osteoarthritis Cartilage 14 (2006) 367-376
42. Lin C.C., Hsiao L.D., Chien C.S., Lee C.W., Hsieh J.T., and Yang C.M. Tumor necrosis factor-α-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: Involvement of p42/p44 and p38 mitogen-activated protein kinases and nuclear factor-kB. Cell. Signal. 16 (2004) 597-607
43. Lyss G., Knorre A., Schmidt T.J., Pahl H.L., and Merfort I. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kB by directly targeting p65. J. Biol. Chem. 273 (1998) 33508-33516
44. Ma Z., Shah R.C., Chang M.J., and Benveniste E.N. Coordination of cell signaling, chromatin remodeling, histone modifications, and regulator recruitment in human matrix metalloproteinase 9 gene transcription. Mol. Cell. Biol. 24 (2004) 5496-5509
45. Mautino G., Oliver N., Chanez P., Bousquet J., and Capony F. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol. 17 (1997) 583-591
46. Moon S.K., Cha B.Y., and Kim C.H. ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kB and AP-1: Involvement of the Ras dependent pathway. J. Cell. Physiol. 198 (2004) 417-427
47. Mukhopadhyay S., Munshi H.G., Kambhampati S., Sassano A., Platanias L.C., and Stack M.S. Calcium-induced matrix metalloproteinase 9 gene expression is differentially regulated by ERK1/2 and p38 MAPK in oral keratinocytes and oral squamous cell carcinoma. J. Biol. Chem. 279 (2004) 33139-33146
48. Nee L.E., McMorrow T., Campbell E., Slattery C., and Ryan M.P. TNF-α and IL-1β-mediated regulation of MMP-9 and TIMP-1 in renal proximal tubular cells. Kidney Int. 66 (2004) 1376-1386
49. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., Yamashita K., and Hayakawa T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267 (1992) 21712-21719
50. Partridge C.A., Jeffrey J.J., and Malik A.B. A 96-kDa gelatinase induced by TNF-α contributes to increased microvascular endothelial permeability. Am. J. Physiol. 265 (1993) 438-447
51. Ries C., Kolb H., and Petrides P.E. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 83 (1994) 3638-3646
52. Robinson M.J., and Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9 (1997) 180-186
53. Sasaki M., Kashima M., Ito T., Watanabe A., Izumiyama N., Sano M., Kagaya M., Shioya T., and Miura M. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1β and TNF-α. Mediat. Inflamm. 9 (2000) 155-160
54. Sato H., Kita M., and Seiki M. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268 (1993) 23460-23468
55. Sato T., Ito A., Ogata Y., Nagase H., and Mori Y. Tumor necrosis factor α (TNFα) induces pro-matrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1α antagonizes the inductive effect of TNFα. FEBS Lett. 392 (1996) 175-178
56. Schwingshackl A., Duszyk M., Brown N., and Moqbel R. Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-α. J. Allergy Clin. Immunol. 104 (1999) 983-989
57. Senior R.M., Griffin G.L., Fliszar C.J., Shapiro S.D., Goldberg G.I., and Welgus H.G. Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266 (1991) 7870-7875
58. r 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58 (1998) 1135-1139
59. Simon C., Simon M., Vucelic G., Hicks M.J., Plinkert P.K., Koitschev A., and Zenner H.P. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271 (2001) 344-355
60. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J. Pathol. 200 (2003) 448-464
61. Subbaramaiah K., Hart J.C., and Norton L. Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2. Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J. Biol. Chem. 275 (2000) 14838-14845
62. Vecil G.G., Larsen P.H., Corley S.M., Herx L.M., Besson A., Goodyer C.G., and Yong V.W. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61 (2000) 212-224
63. Vu T.H., and Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 14 (2000) 2123-2133
64. Wang C.C., Lin W.N., Lee C.W., Lin C.C., Luo S.F., Wang J.S., and Yang C.M. Invovlement of p42/p44 MAPK, p38 MAPK, JNK, and NF-kB in IL-1β-induced VCAM-1 expression in human tracheal smooth muscle cells. Am. J. Physiol., Lung Cell. Mol. Physiol. 288 (2005) L227-L237
65. Westermarck J., and Kahari V.M. Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J. 13 (1999) 781-792
66. Woo C.H., Lim J.H., and Kim J.H. Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J. Immunol. 173 (2004) 6973-6980
67. Woo M.S., Jung S.H., Kim S.Y., Hyun J.W., Ko K.H., Kim W.K., and Kim H.S. Curcumin suppresses phorbol ester-induced matrix metalloproteinase-9 expression by inhibiting the PKC to MAPK signaling pathways in human astroglioma cells. Biochem. Biophys. Res. Commun. 335 (2005) 1017-1025
68. Wu C.Y., Hsieh H.L., Jou M.J., and Yang C.M. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-kappa B in interleukin-1beta-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J. Neurochem. 90 (2004) 1477-1488
69. Yang C.M., Luo S.F., Wang C.C., Chiu C.T., Chien C.S., Lin C.C., and Hsiao L.D. Tumor necrosis factor-α- and interleukin-1β-stimulated cell proliferation through activation of mitogen-activated protein kinase in canine tracheal smooth muscle cells. Br. J. Pharmacol. 130 (2000) 891-899
70. Yang C.M., Hsieh S.L., and Lee C.W. Intracellular signaling mechanisms underlying the expression of pro-inflammatory mediators in airway diseases. Chang Gung Med. J. 28 (2005) 813-822
71. Yao P.M., Maitre B., Delacourt C., Buhler J.M., Harf A., and Lafuma C. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1β and TNF-α. Am. J. Physiol., Lung Cell. Mol. Physiol. 273 (1997) L866-L874
72. Yokoo T., and Kitamura M. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am. J. Physiol. 270 (1996) F123-F130
73. Zeigler M.E., Chi Y., Schmidt T., and Varani J. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J. Cell. Physiol. 180 (1999) 271-284